Government Affairs
Refine Search
Pharmaceutical
UK Prime Minister Theresa May today outlined the first steps in a modern, ambitious Industrial Strategy which will build on the UK’s strengths and address the long-term structural challenges which can hold British businesses back. 21 November 2016
Pharmaceutical
The Russian pharmaceutical market is one of the fastest growing in the world, and this overview describes the main regulatory trends, associated legal risks and opportunities for pharma manufacturers in 2016-2017 in Russia. 21 November 2016
Biotechnology
The Japanese government has slashed the price of the multi-indication cancer drug Opdivo by half. 17 November 2016
Pharmaceutical
Speculation is rife about what Donald Trump’s election win means for pharma and health care in the USA, but what of its potential impact on the industry in Europe? Novasecta’s Salma Ajraoui analyzes the issue. 15 November 2016
Pharmaceutical
With the coming of the 25th“World Diabetes Day,” R&D Based Pharmaceutical Association Committee of China Association of Enterprises with Foreign Investment (RDPAC) released Faces of Innovation: Meeting the Challenge of Diabetes today in Beijing. 14 November 2016
Pharmaceutical
Investors in the beaten down biotech sector finally got an unexpected reprieve this week, thanks mainly due to the unexpected "clean sweep" of the US Congress and the presidency by the Republican party. 13 November 2016
Biotechnology
The UK’s Court of Appeal has ruled that National Health Service (NHS) in England has the power to fund Pre-Exposure Prophylaxis (PrEP) for HIV. 10 November 2016
Biotechnology
Rather than uncertainty about what the Presidency of Donald Trump might mean for drug prices, many pharma and biotech stocks jumped considerably after the Republican nominee gained a shock election victory over Democrat Hillary Clinton. 9 November 2016
Pharmaceutical
A plea has been made to Liam Fox, the UK’s Secretary of State for International Trade, calling on him to clarify what relationship the UK will have with the European Medicines Agency (EMA) as the government presses on with its plans for Brexit. 8 November 2016
Generics
The current US Food and Drug Administration system to announce hotly contested generic drug approval decisions is broken, say legal experts. 7 November 2016
Pharmaceutical
The Indian government will soon come up with a new pharma policy to counter the excessive controls thwarting competitiveness and innovation in the sector. 4 November 2016
Pharmaceutical
The Russian Ministry of Health has approved the list of vaccines that will be produced in Russia in the coming years, according to recent statements by Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent. 3 November 2016
Biotechnology
In response to the ‘Ferris, Finkel, Fraser’ Review of the Research & Development Tax Incentive, trade group AusBiotech says it does not support the proposed changes as a package, as it is a firm belief that this effort to limit or divert the R&D Tax Incentive will damage its hard-won momentum in life sciences, especially the stimulation of the clinical trials environment – and argues that any change ought to exclude and keep from harm R&D in clinical trials. 2 November 2016
Pharmaceutical
Innovation-driven development is a core strategy of China’s 13th Five-Year (2016-2020) Plan and biomedicine is a key driver of that innovation. Pharmaceutical innovation is not only an engine for long-term economic development but also contributes to people’s welfare. 1 November 2016
Pharmaceutical
“With just under 10 years left to meet the target of reducing premature deaths from non-communicable (NCDs) diseases by 25%, governments and policy-makers must act now to ensure equitable access to services to allow people to live with and survive cancer.” 1 November 2016
Pharmaceutical
Trade group Pharma Industry Finland (PIF) is warmly in favor of Member of Parliament Annika Saarikko’s proposal to move the European Medicines Agency (EMA) to Finland. 30 October 2016
Pharmaceutical
A new report published by the UK government today, puts forward a number of recommendations aimed at speeding up the process by which the NHS implements newly developed drugs and medical procedures. 24 October 2016
Pharmaceutical
Cuba and the USA on Thursday signed an agreement to cooperate on cancer research as part of a visit to the island nation by US Secretary of Health and Human Services Sylvia Burwell. 21 October 2016
Pharmaceutical
In our weekly expert view piece, Rohit Malpani, director of policy and analysis for Mèdecins Sans Frontiéres Access Campaign, discusses the UN Secretary General's High-Level Panel report on Access to Medicines and looks at the responsibilities it places on industry. 17 October 2016
Generics
Prices for cheap drugs from the list of vital medicines may significantly increase in Russia this year due to a recent decision by the Russian government to refrain from further state regulation of prices for drugs from this segment. 17 October 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze